Breaking News

PAREXEL Expands Data-Driven Monitoring Platform

Aims to enhance oversight and control of site-related risk, quality, and performance

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL expanded its Perceptive MyTrials Data-Driven Monitoring (DDM) solution with next generation risk-based monitoring capabilities allowing clients to perform cross-study analysis of quality, risk, and monitoring work effort by combining analytics, reporting and monitoring activity into a single solution.The enhancement aims to increase a drug developer’s ability to demonstrate oversight and control of site-related risk, quality, and performance. “Centralized monitoring methods ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters